Prevention of cytomegalovirus disease after heart transplantation: preemptive therapy with 7 days' intravenous ganciclovir.
Paniagua
M J
MJ
Programa de Trasplante Cardiaco, Hospital Juan Canalejo, Instituto Universitario Ciencias de la Salud, Universidad de A Coruña, Spain. Maria_Paniagua@canalejo.org
Crespo-Leiro
M G
MG
De la Fuente
L
L
Tabuyo
T
T
Mosquera
I
I
Cañizares
A
A
Naya
C
C
Fariña
P
P
Juffé
A
A
Castro-Beiras
A
A
D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use*; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control / Q000821:virology*; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D015774:Ganciclovir